Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A2 activity in a murine asthma model.

MLA

Ko, H. M., et al. “Glutamine Preferentially Inhibits T-Helper Type 2 Cell-Mediated Airway Inflammation and Late Airway Hyperresponsiveness through the Inhibition of Cytosolic Phospholipase A2 Activity in a Murine Asthma Model.” Clinical & Experimental Allergy, vol. 38, no. 2, Feb. 2008, pp. 357–64. EBSCOhost, https://doi.org/10.1111/j.1365-2222.2007.02900.x.

APA

Ko, H. M., Kang, N. I., Kim, Y. S., Lee, Y. M., Jin, Z. W., Jung, Y. J., Im, S. Y., Kim, J. H., Shin, Y. H., Cho, B. H., & Lee, H. K. (2008). Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A2 activity in a murine asthma model. Clinical & Experimental Allergy, 38(2), 357–364. https://doi.org/10.1111/j.1365-2222.2007.02900.x

Chicago

Ko, H. M., N. I. Kang, Y. S. Kim, Y. M. Lee, Z. W. Jin, Y. J. Jung, S. Y. Im, et al. 2008. “Glutamine Preferentially Inhibits T-Helper Type 2 Cell-Mediated Airway Inflammation and Late Airway Hyperresponsiveness through the Inhibition of Cytosolic Phospholipase A2 Activity in a Murine Asthma Model.” Clinical & Experimental Allergy 38 (2): 357–64. doi:10.1111/j.1365-2222.2007.02900.x.